ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2018 American Transplant Congress

    Rituximab Induction to Prevent the Recurrence of PSC after Liver Transplantation-The Lessons Learned from ABO-Incompatible Living Donor Liver Transplantation-

    Y. Yamada,1 K. Hoshino,1 M. Shinoda,1 H. Obara,1 S. Uemoto,3 T. Kaido,3 H. Okajima,3 T. Yagi,4 T. Yoshizumi,5 Y. Inomata,6 T. Hibi,6 K. Kubota,7 T. Suzuki,8 Y. Kitagawa,1 H. Egawa,2 T. Kuroda.1

    1Surgery, Keio University School of Medicine, Tokyo, Japan; 2Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan; 3Division of Hepato-Biliary-Pancreatic Surgery and Transplant Surgery, Kyoto University, Kyoto, Japan; 4Hepato-Biliary and Pancreatic Surgery, Okayama University, Okayama, Japan; 5Department of Surgery, Kyushu University, Fukuoka, Japan; 6Transplantation and Pediatric Surgery, Kumamoto University, Kumamoto, Japan; 7Department of Gastroenterological Surgery, Dokkyo Medical University, Tochigi, Japan; 8Department of Pediatric Surgery, Fujita Health University School of Medicine, Aichi, Japan.

    Background: Multiple studies have failed to reveal an effective method for preventing the recurrence of primary sclerosing cholangitis (PSC) after liver transplantation (LTx). A national…
  • 2018 American Transplant Congress

    Surgical Categorization Improve Outcomes and Organ Utilization in Liver Transplant

    H. Bohorquez,1,2 H. Sharma,1 D. Bruce,1 A. Cohen,1,2 C. Carmody,1,2 J. Seal,1 E. Bugeaud,1 D. Sonnier,1 A. Mathur,1 D. Marroquin,1 M. Voltz,1 D. Lucia,1 G. Loss.1,2

    1Multi-Organ Transplant Institute, Ochsner Helath System, New Orleans, LA; 2School of Medicine, University of Queensland, New Orleans, LA.

    Background: Liver transplant (LT) varies greatly in technical complexity due to factors such as prior surgery, obesity, and portal vein thrombosis (PVT). This must be…
  • 2018 American Transplant Congress

    Impact of Positive Donor Blood Cultures in Liver Transplant Recipients

    D. Bley, D. Lo, G. Lyon III, R. Subramanian, S. Todd.

    Emory University Hospital, Atlanta, GA.

    The purpose of this study was to describe the bacteremia transmission rate of transplanting livers from donors with positive bacterial blood cultures into liver transplant…
  • 2018 American Transplant Congress

    Preoperative Antibiotics Treatment Decreases Endoplasmic Reticulum Stress and Protects Liver Transplant from Ischemia-Reperfusion Injury

    T. Ito, F. Kaldas, K. Nakamura, S. Kageyama, A. Aziz, R. Busuttil, J. Kupiec-Weglinski.

    Department of Surgery, The Dumont-UCLA Transplant Center, Los Angeles, CA.

    Ischemia-reperfusion injury (IRI) represents a major risk factor of graft dysfunction in liver transplantation (LT). We have reported a critical role of endoplasmic reticulum (ER)…
  • 2018 American Transplant Congress

    Single-Dose Basiliximab Induction in Liver Transplant Recipients with Delayed CNI Initiation

    D. Salerno,1 N. Lange,1 R. Rosenblatt,2 C. Sammons,3 B. Fortune.2

    1Pharmacy, NewYork-Presbyterian Hospital, New York, NY; 2Medicine, Weill Cornell Medicine, New York, NY; 3Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA.

    Liver transplant recipients (LTR) with peri-operative renal injury benefit from a delayed CNI protocol using basiliximab (IL2RA) induction to reduce early CNI exposure. Existing literature…
  • 2018 American Transplant Congress

    Impact of Preserved Collateral Veins on Small-for-Size Grafts in Living Donor Liver Transplantation

    B-.G. Na, E. Lee, S. Kim, S. Park.

    Center for Liver Cancer, National Cancer Center Research Institute, Goyang, Republic of Korea.

    Purpose: Graft size is a critical issue in living donor liver transplantation (LDLT). We hypothesized that too much portal flow could possibly be diverted into…
  • 2018 American Transplant Congress

    Clinical Application of Mesenchymal Stromal Cells with a Simplified Protocol for ABO Incompatible Liver Transplantation in Severe Hepatic Failure Patients

    Y. Zhang,1,2 J. Zheng,1,2 J. Cai,1,2 J. Zhang,1,2 K. Zeng,1,2 J. Yao,1,2 Y. Yang.1,2

    1Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Guangzhou, Guangdong, China; 2Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, .

    Objective The purpose of this study was to test the safety and efficacy of mesenchymal stromal cells (MSCs) treatment with a simplified protocol for ABO…
  • 2018 American Transplant Congress

    Normothermic Machine Perfusion (NMP) Preservation for Human Liver Transplantation in the Cleveland Clinic

    Q. Liu, D. Pezzati, A. Hassan, B. Soliman, P. Grady, S. Maikhor, G. Iuppa, T. Diago Uso, K. Hashimoto, F. Aucejo, M. Fujiki, B. Eghtesad, J. Cywinski, S. Irefin, J. Fung, K. Abu-Elmagd, C. Miller, C. Quintini.

    Cleveland Clinic, Cleveland, OH.

    NMP is a novel preservation method for liver grafts. We transplanted 15 human livers after NMP to test the safety and feasibility of NMP on…
  • 2018 American Transplant Congress

    Serelaxin-Notch1 Signaling Promotes Macrophage M2 Differentiation and Alleviates Hepatocellular Damage in Orthotopic Liver Transplantation: From Mouse-to-Human

    S. Kageyama,1 K. Nakamura,1 B. Ke,1 R. Sosa,2 E. Reed,2 F. Kaldas,1 R. Busuttil,1 J. Kupiec-Weglinski.1

    1Surgery, Liver Transplant, UCLA, Los Angeles, CA; 2Pathology, UCLA, Los Angeles, CA.

    Background/Aim: We have documented crucial role of macrophage Notch1 signaling in a mouse warm hepatic ischemia-reperfusion injury (IRI) model. However, its clinical relevance or therapeutic…
  • 2018 American Transplant Congress

    Examples of the Observer Effect in Transplantation- Unintended Consequences of Regulation and Selected Outcome Metrics

    A. Rana, M. Kueht, N. Galvan, R. Cotton, C. O'Mahony, J. Goss.

    Abdominal Transplantation, Baylor College of Medicine, Houston, TX.

    Introduction: The influence of an observer on the phenomena being observed is designated as the observer effect. It is our aim to demonstrate that an…
  • « Previous Page
  • 1
  • …
  • 118
  • 119
  • 120
  • 121
  • 122
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences